Welcome to the Office of Cancer Survivorship Program, DCCPS
The NCI Office of Cancer Survivorship (OCS) works to enhance the quality and length of survival of all persons diagnosed with cancer and to prevent, minimize, or manage adverse effects of cancer and its treatment.
December 2022 – Join the Office of Cancer Survivorship on December 13, 2022, 2-3 p.m. ET for the next OCS Director’s Series webinar. Dr. Laura A. Petrillo will present Blending Survivorship and Palliative Care for People with Advanced Cancer in the Precision Oncology Era, and cancer survivor and advocate Dr. Anne Charity Hudley will share her experiences. Register now for this upcoming event.
January 2023 – Register now for this upcoming OCS Director’s Series webinar. On January 24, 2023, from 2-3 p.m. ET, Dr. Dawn Konrad-Martin will present Hear Today and Tomorrow: Unmet Needs and Opportunities for Improving Hearing Health in Cancer Survivors. She will be joined by cancer survivor and retired audiologist Dr. Deborah L Berndtson, who will share her experiences.
OCS created the New Investigators Series to support those who are early in their career in cancer survivorship research. Find recordings from successful researchers, and check back again as more recordings are added.
September 2022 – NCI researchers report that as of 2018, there were an estimated 623,405 people living with metastatic breast, prostate, lung, colorectal, or bladder cancer or metastatic melanoma, and that number is expected to increase to 693,452 by the year 2025. View the article in JNCI.
About The Office of Cancer Survivorship
An individual is considered a cancer survivor from the time of diagnosis, through the balance of life. There are many types of survivors, including those living with cancer and those free of cancer. This term is meant to capture a population of those with a history of cancer rather than to provide a label that may or may not resonate with individuals.
OCS works to promote a better understanding of unique needs of the growing population of cancer survivors, and to enhance our ability to address them.
Featured Graph and Statistic
Researchers at the National Cancer Institute have estimated that 623,405 people in the United States were living with metastatic breast, prostate, lung, colorectal, or bladder cancer or metastatic melanoma as of 2018, and that number is expected to increase to 693,452 by the year 2025.